NAVLE Integumentary

Equine Allergies and Immune Hypersensitivity Reactions – NAVLE Study Guide

Allergic skin diseases are among the most common dermatological conditions affecting horses worldwide.

Overview and Clinical Importance

Allergic skin diseases are among the most common dermatological conditions affecting horses worldwide. These immune-mediated disorders result from exaggerated or inappropriate immune responses to typically harmless environmental antigens, leading to significant morbidity and welfare concerns. Understanding the pathophysiology, clinical presentation, and management of equine allergies is essential for NAVLE success and clinical practice.

The Gell and Coombs classification system categorizes hypersensitivity reactions into four types, each involving distinct immunological mechanisms. In equine dermatology, Type I (immediate) and Type IV (delayed) hypersensitivity reactions are most commonly implicated in allergic skin diseases. Insect bite hypersensitivity (IBH), also known as "sweet itch," represents the most common allergic skin disease in horses globally.

Type Mechanism Mediators Equine Examples
Type I (Immediate) IgE-mediated mast cell degranulation IgE, mast cells, histamine, leukotrienes, prostaglandins IBH (sweet itch), urticaria, anaphylaxis, atopic dermatitis
Type II (Cytotoxic) IgG/IgM antibodies against cell surface antigens IgG, IgM, complement, NK cells Neonatal isoerythrolysis, pemphigus foliaceus, drug-induced hemolytic anemia
Type III (Immune Complex) Immune complex deposition in tissues IgG, complement, neutrophils Purpura hemorrhagica, equine recurrent uveitis, hypersensitivity pneumonitis
Type IV (Delayed) T-cell mediated, 24-72 hours post-exposure T lymphocytes, cytokines, macrophages Allergic contact dermatitis, tuberculin skin test reaction, component of IBH

Classification of Hypersensitivity Reactions

The Gell and Coombs classification divides hypersensitivity reactions into four types based on immunological mechanisms. Understanding these mechanisms is fundamental to diagnosing and treating equine allergic diseases.

Summary of Hypersensitivity Types

High-YieldInsect bite hypersensitivity (IBH) involves BOTH Type I (immediate IgE-mediated) AND Type IV (delayed T-cell mediated) hypersensitivity reactions. This dual mechanism explains why clinical signs can develop within minutes to hours AND continue for days after insect exposure.
Category Clinical Findings
Primary Lesions Papules, wheals, erythema
Secondary Lesions Excoriations, alopecia, broken hairs, crusts, scaling, lichenification (chronic), hyperkeratosis
Dorsal Distribution Mane, withers, back, tail head, ears (dorsal-feeding Culicoides species)
Ventral Distribution Ventral abdomen, chest, groin, face (ventral-feeding species)
Seasonality Spring through autumn in temperate climates; remission during winter; year-round in tropical/subtropical regions
Behavioral Signs Intense rubbing against objects, tail swishing, stomping, restlessness, irritability, weight loss (severe cases)

Insect Bite Hypersensitivity (Sweet Itch)

Insect bite hypersensitivity (IBH) is the most common allergic skin disease in horses worldwide. Also known as "sweet itch," "Queensland itch," "summer eczema," or "Kasen," this condition results from an allergic response to salivary proteins of biting insects, most commonly Culicoides species (biting midges or "no-see-ums").

Etiology and Pathogenesis

Causative Agents: The primary causative agents include Culicoides species (most common), black flies (Simulium spp.), stable flies (Stomoxys spp.), horse flies, deer flies, horn flies, and mosquitoes. Culicoides midges are the most important causative agents, with over 1,000 species worldwide. Different species have varying feeding preferences, with some being dorsal feeders (affecting mane and tail) and others being ventral feeders (affecting abdomen).

Immunological Mechanism: When a female Culicoides midge feeds, it injects saliva containing vasodilators, anticoagulants, and pro-inflammatory mediators. In sensitized horses, allergen-specific IgE antibodies bind to these salivary proteins, triggering mast cell degranulation and release of histamine and inflammatory mediators. The condition involves both Type I (immediate) and Type IV (delayed) hypersensitivity, explaining the complex clinical presentation.

Genetic Predisposition: Genetic factors play a significant role, with certain breeds showing increased susceptibility including Icelandic horses (especially those exported from Iceland), Welsh ponies, Shire horses, Friesian horses, and German Shire horses. High IgE levels in horses are associated with certain ELA-DRB haplotypes.

Clinical Signs and Distribution

The cardinal sign of IBH is intense, extreme pruritus with characteristic distribution patterns. Clinical signs typically first appear between 2-4 years of age and generally worsen with age and repeated exposure.

Diagnosis

IBH is primarily a clinical diagnosis based on compatible history (seasonality, recurrence), characteristic clinical signs and distribution, exclusion of other pruritic skin diseases, and favorable response to insect control measures. Allergy testing (intradermal or serological) supports but does not definitively establish the diagnosis.

Diagnostic Approach

Treatment and Management

Insect avoidance is the cornerstone of IBH management. A multimodal approach combining environmental management, physical barriers, pharmacological therapy, and potentially immunotherapy provides the best outcomes.

NAVLE TipWhen you see a pruritic horse with seasonal distribution affecting the mane, tail, and dorsum, think IBH first. Remember: SEPARATION is key - separate the bug from the horse through stabling during dusk/dawn, fans, fly sheets, and environmental modification. Pharmacological therapy addresses symptoms but does not cure the underlying allergy.
Method Details and Considerations
History and Clinical Exam Assess seasonality, age of onset, distribution of lesions, response to previous treatments, breed predisposition
Rule Out Differentials Exclude ectoparasites (lice, mites), dermatophytosis, dermatophilosis, pemphigus foliaceus, onchocerciasis
Intradermal Testing Gold standard for identifying specific allergens; requires drug withdrawal (steroids 3-6 weeks, antihistamines 10 days); readings at 15-30 min, 4 hours, and 24 hours
Serology (IgE) Less reliable than intradermal testing; no drug withdrawal required; useful screening tool but false positives/negatives common
Histopathology Supports diagnosis but not pathognomonic; shows subepidermal edema, eosinophilic/lymphocytic perivascular dermatitis, mast cells
Response to Treatment Positive response to insect avoidance measures strongly supports diagnosis

Urticaria (Hives)

Urticaria is a common cutaneous reaction pattern in horses characterized by the sudden appearance of raised, edematous wheals. It is more frequently reported in horses than any other domestic species. Urticaria is not a disease itself but rather a clinical manifestation of various etiopathological processes.

Etiology and Classification

Urticaria can result from immunological or non-immunological mechanisms. The classic mechanism involves Type I hypersensitivity with mast cell degranulation, histamine release, and increased vascular permeability leading to dermal edema.

Clinical Presentation

Urticarial lesions are characterized by raised, round, flat-topped wheals ranging from 0.5 to 8 inches (1-20 cm) in diameter. They may be slightly depressed in the center and demonstrate pitting edema on digital pressure. Various morphological patterns have been described:

  • Localized or generalized papules/plaques: Most common presentation
  • Giant urticaria: Large confluent areas of swelling
  • Linear pattern: Following contact with allergen
  • Gyrate patterns: Arciform, serpiginous, annular ("doughnut-shaped")
  • Angioedema: Deep dermal/subcutaneous swelling, commonly affecting muzzle and eyelids

Hives typically appear on the back, flanks, neck, eyelids, and legs. They develop within minutes to hours of exposure and often resolve within 24-48 hours. Pruritus is variable. When hives persist beyond 6-8 weeks, the condition is considered chronic.

Diagnosis and Treatment

Diagnosis is usually straightforward based on clinical appearance. The challenge lies in identifying the underlying cause. A thorough history evaluating recent exposures (medications, vaccines, feed changes, environmental factors) is essential.

High-YieldDrug-induced urticaria may occur with FIRST exposure if the agent is urticariogenic (morphine, atropine, dextran). However, true immune-mediated drug reactions require prior sensitization and typically occur 1-3 weeks after starting the medication. Common culprits include penicillin, trimethoprim-sulfa, phenylbutazone, and vaccines.
Treatment Category Specific Interventions
Environmental Management Stable horses during peak Culicoides activity (dusk and dawn) Use fans in stables (midges are weak fliers) Install fine mesh screens on stable doors/windows Remove standing water and reduce breeding sites Avoid pastures near ponds, bogs, or slow-moving water
Physical Barriers Full-body fly sheets with neck, belly, and tail coverage Fly masks protecting face and ears Leg boots/wraps for ventral feeders
Insect Repellents Permethrin-based products (most effective) Benzyl benzoate preparations Apply to high-risk areas; reapply as directed
Corticosteroids Prednisolone: 0.5-2 mg/kg PO q24h, taper to lowest effective dose Dexamethasone: 0.02-0.1 mg/kg PO/IM q24h Caution: Risk of laminitis, especially with prolonged use; prednisolone preferred over dexamethasone
Antihistamines Hydroxyzine: 0.5-2 mg/kg PO q8-12h (most effective) Cetirizine: 0.2-0.4 mg/kg PO q12h Note: More effective for prevention than treatment of active lesions
Omega-3 Fatty Acids Flaxseed or flaxseed oil supplementation; shown to reduce allergic skin reactions by modulating inflammatory response; requires 6-8 weeks to show benefit
Immunotherapy Allergen-specific immunotherapy (ASIT) based on intradermal testing; variable success reported; requires months to years for full effect; current evidence does not strongly support commercial Culicoides extracts

Atopic Dermatitis (Environmental Allergy)

Equine atopic dermatitis is the second most common allergic skin disease in horses after IBH. It represents a hypersensitivity to environmental allergens such as pollens (trees, grasses, weeds), molds, dust mites, and storage mites.

Clinical Features: Pruritus (variable severity), recurrent urticaria, papules, and crusting. Distribution may be generalized or localized to face, neck, and limbs. Seasonality depends on the specific allergens involved - pollen allergies cause summer signs while dust/storage mite allergies may cause year-round or winter exacerbation (when horses are stabled more).

Diagnosis: Made by compatible history and clinical signs after excluding other causes of pruritus. Intradermal testing is the gold standard for identifying specific allergens. IgE serological testing is available but less reliable.

Treatment: Environmental modification to reduce allergen exposure, symptomatic therapy with corticosteroids and antihistamines, and allergen-specific immunotherapy (ASIT). Studies suggest 60-85% of horses show improvement with immunotherapy, though response may take months to years.

Category Specific Triggers
Immunological Insect bites/stings, atopic dermatitis, food reactions (wheat, oats, barley, alfalfa), drug reactions (antibiotics, phenylbutazone, NSAIDs, vaccines), blood transfusion reactions
Physical Cold-induced urticaria, heat-induced (cholinergic) urticaria, pressure urticaria (dermographism), exercise-induced urticaria, solar urticaria
Infections/Parasites Bacterial infections, viral infections, fungal infections, endoparasites, ectoparasites
Psychogenic Stress (transport, new environment, competition), anxiety
Idiopathic No identifiable cause (up to 75% of cases); represents diagnostic challenge

Contact Dermatitis

Allergic contact dermatitis is a Type IV (delayed) hypersensitivity reaction occurring when sensitizing chemicals contact the skin. It is relatively uncommon in horses but can cause significant clinical disease.

Common Allergens: Fly sprays, shampoos, liniments, blanket materials, tack components, topical medications (neomycin), plants, and bedding materials.

Clinical Signs: Erythema, pruritus, papules, vesicles, scaling, crusting, and alopecia in areas of direct contact. Distribution corresponds to contact area (e.g., girth area from tack, lower limbs from pasture plants, face from fly mask).

Diagnosis: Based on history of exposure and distribution of lesions. Removal of suspected allergen followed by rechallenge confirms diagnosis. Patch testing can be performed but is not widely standardized in horses.

Treatment: Identify and eliminate the offending substance. Symptomatic treatment with topical or systemic corticosteroids. Treat secondary bacterial infections if present.

Clinical Scenario Management Approach
Mild Acute Urticaria Often self-limiting; observation ("benign neglect") may be sufficient; remove suspected trigger if identified
Moderate-Severe Acute Dexamethasone: 0.02-0.1 mg/kg IV/IM Antihistamines: Hydroxyzine 0.5-2 mg/kg PO NSAIDs (Banamine) for associated discomfort
With Angioedema Corticosteroids (dexamethasone); monitor airway if facial swelling; epinephrine if respiratory compromise (0.01-0.02 mg/kg IM/SC)
Chronic/Recurrent Investigate underlying cause thoroughly Elimination diet trial (4-6 weeks) if food suspected Intradermal allergy testing Consider allergen-specific immunotherapy Long-term low-dose prednisolone if needed

Food Allergy

Food allergies are rare in horses but have been documented. They may involve Type I, III, or IV hypersensitivity reactions.

Suspected Allergens: Oats, wheat, barley, bran, alfalfa, corn, soy, feed additives, and supplements.

Clinical Signs: Pruritus affecting face, neck, trunk, and tail ("tail rubbers"). Pruritic or non-pruritic urticaria. Signs may be perennial or seasonal if related to pasture plants.

Diagnosis: Elimination diet for 4-6 weeks using a novel protein source (e.g., all-grass hay diet - timothy only). Improvement followed by recurrence upon rechallenge confirms diagnosis. Serological tests (RAST, ELISA) for food allergies are unreliable and not recommended.

Treatment: Strict avoidance of the offending food. This may be challenging given the complexity of equine diets and the need for adequate nutrition.

Clinical Signs Emergency Treatment
Cardiovascular: Hypotension, weak/rapid pulse, pale mucous membranes, cold extremities, collapse Respiratory: Sudden dyspnea, increased respiratory effort, bronchoconstriction Dermatological: Acute urticaria (may or may not be present), facial swelling/angioedema GI: Colic signs (intestine is a target organ) Other: Anxiety, restlessness, recumbency 1. EPINEPHRINE: 0.01-0.02 mg/kg IV, IM, or SC (drug of choice) 2. Establish IV access: Large-bore catheter 3. IV Fluids: Aggressive crystalloid therapy for shock 4. Corticosteroids: Dexamethasone 0.1-0.2 mg/kg IV 5. Oxygen: If available 6. Secure airway: Emergency tracheotomy if severe laryngeal edema

Anaphylaxis

Anaphylaxis is a rare, life-threatening, systemic Type I hypersensitivity reaction requiring immediate intervention. In horses, target organs include the lungs and intestines.

Common Triggers: Drug administration (penicillin, vaccines, vitamin E-selenium preparations, iron dextrans), blood transfusions, insect stings, and snake bites.

High-YieldEPINEPHRINE is the FIRST-LINE drug for anaphylaxis. It provides alpha-adrenergic effects (vasoconstriction, increased blood pressure), beta1-adrenergic effects (increased heart rate and contractility), and beta2-adrenergic effects (bronchodilation, inhibition of mast cell degranulation). Do NOT delay epinephrine administration while preparing other treatments.

Diagnostic Approach to the Pruritic Horse

A systematic approach is essential when evaluating horses with suspected allergic skin disease. The following algorithm helps guide clinical decision-making.

Step-by-Step Diagnostic Approach

  • Complete history: Age of onset, seasonality, distribution, progression, response to previous treatments, diet, environment, recent medications
  • Physical examination: Distribution and character of lesions, presence of primary vs. secondary lesions
  • Rule out ectoparasites: Skin scraping, hair plucks, coat brushing for lice
  • Rule out infectious causes: Fungal culture (dermatophytosis), cytology (bacterial/yeast infection), impression smears
  • Treat secondary infections: Before further allergy workup
  • Elimination diet trial: If food allergy suspected (4-6 weeks)
  • Insect control trial: Strict avoidance measures for IBH
  • Allergy testing: Intradermal skin testing (gold standard) or serology if atopic dermatitis confirmed clinically
  • Skin biopsy: If diagnosis remains uncertain; supportive but rarely diagnostic

Practice NAVLE Questions

Test your knowledge with 10,000+ exam-style questions, detailed explanations, and timed exams.

Start Your Free Trial →